The binary phase diagram of propranolol hydrochloride and crystallization-based enantioseparation

Journal of Pharmaceutical Sciences

Volumn 99, Issue 4, 2010, Pages 1762-1773

  Polenske, Daniel ^a   Lorenz, Heike ^a   Seidel Morgenstern, Andreas ^a,b  

^a MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Binary phase diagram; Calorimetry (DSC); Chiral resolution; Conglomerate; Crystallization; Polymorphism; Propranolol hydrochloride; Racemic compound; Separation science; Solid solutions; Thermal analysis; X ray powder diffraction

Indexed keywords

PROPRANOLOL;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; ENANTIOMER; ENTHALPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MISCIBILITY; SOLID STATE; THERMODYNAMICS; X RAY POWDER DIFFRACTION;

EID: 77949797572     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21943     Document Type: Article

References (30)

1. Li ZJ, Zell MT, Munson EJ, Grant DJW. 1999. Characterization of racemic species of chiral drugs using thermal analysis, thermodynamic calculation, and structural studies. J Pharm Sci 88:337-346.
2. Rouhi AM. 2004. Chiral chemistry. Chem Eng News 82:47-62.
3. Drayer DE. 1986. Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview. Clin Pharmacol Ther 40: 125-133.
4. Mitchell AG. 1998. Racemic drugs: Racemic mixture, racemic compound, or pseudoracemate? J Pharm Pharmaceut Sci 1:8-12.
5. Collins AN, Sheldrake GN, Crosby J, editors. 1992. Chirality in industry: The commercial manufacture and applications of optically active compounds. Chichester, USA: John Wiley & Sons.
6. Collins AN, Sheldrake GN, Crosby J, editors. 1997. Chirality in industry. II. Developments in the manufacture and applications of optical active compounds. Chichester, USA: John Wiley & Sons.
7. Jaques J, Collet A, Wilen SH. 1994. Enantiomers, racemates and resolutions. Malabar, FL: Krieger Publishing Company.
8. Lorenz H, Perlberg A, Sapoundjiev D, Elsner MP, Seidel-Morgenstern A. 2006. Crystallization of enantiomers. Chem Eng Process 45:863-873.
9. Li ZJ, Grant DJW. 1997. Relationship between physical properties and crystal structures of chiral drugs. J Pharm Sci 86:1073-1078.
10. Ströhlein G, Schulte M, Strube J. 2003. Hybrid processes: Design method for optimal coupling of chromatography and crystallization units. Sep Sci Technol 38:3353-3383.
11. Ndzié E, Ludemann-Hombourger O, Bléhaut J, Perrin SR, Hauck W. 2003. Coupling chromatography with crystallization: Global purification process. In: Coquerel G, editor. Proceedings of the 10th International Workshop on Industrial Crystallization (BIWIC 2003). Rouen, France: Université de Rouen. pp. 87-94.
12. Lorenz H, Sheehan P, Seidel-Morgenstern A. 2001. Coupling of simulated moving bed chromatography and fractional crystallisation for efficient enantioseparation. J Chromatogr A 908:201-214.
13. Kaspereit M. 2006. Separation of enantiomers by a process combination of chromatography and crystallization. Ph.D. thesis, Otto-von-Guericke- Universität Magdeburg, Aachen, Deutschland: Shaker Verlag.
14. Lorenz H, Polenske D, Seidel-Morgenstern A. 2006. Application of preferential crystallisation to resolve racemic compounds in a hybrid process. Chirality 18:828-840.
15. Polenske D, Lorenz H, Seidel-Morgenstern A. 2009. Potential of different techniques of preferential crystallization for enantioseparation of racemic compound forming systems. Chirality 21:728-737.
16. Bartolomei M, Bertocchi P, Ramusino MC, Signoretti EC. 1998. Thermal studies on the polyphormic modifications of (R,S) propranolol hydrochloride. Thermochim Acta 321:43-52.
17. Henck J-O, Kuhnert-Brandstätter M. 1999. Demonstration of the terms enantiotropy and monotropy in polymorphism research exemplified by flurbiprofen. J Pharm Sci 88:103-108.
18. Threlfall TL. 1995. Analysis of organic polymorphs. Analyst 120:2435-2460.
19. Elsabee M, Prankerd RJ. 1992. Solid-state properties of drugs. III. Differential scanning calorimetry of chiral drug mixtures existing as racemic solid solutions, racemic mixtures or racemic compounds. Int J Pharm 86:221-230.
20. Neau SH, Shinwari MK, Hellmuth EW. 1993. Melting point phase diagrams of free base and hydrochloride salts of bevantolol, pindolol and propranolol. Int J Pharm 99:303-310.
21. Wang X, Wang XJ, Ching CB. 2002. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride. Chirality 14:318-324.
22. Bredikhin AA, Savel'ev DV, Bredikhina ZA, Gubaidullin AT, Litvinov H. 2003. Crystallization of chiral compounds 2. Propranolol: Free base and hydrochloride. Russ Chem Bull 52:853-861.
23. Bartolomei M, Bertocchi P, Ramusino MC, Santucci N, Valvo L. 1999. Physico-chemical characterisation of the modifications I and II (R,S) propranolol hydrochloride: Solubility and dissolution studies. J Pharm Biomed Anal 21:299-309.
24. Kuhnert-Brandstätter M, Völlenklee R. 1985. Thermoanalytische und IR-spektroskopische Untersuchungen an polymorphen Arzneistoffen: Acemetacin, Piroxicam, Propranololhydrochlorid und Urapidil. Fresenius Z Anal Chem 322:164-167.
25. Lorenz H, Seidel-Morgenstern A. 2002. Binary and ternary phase diagrams of two enantiomers in solvent systems. Thermochim Acta 382:129-142.
26. International Centre for Diffraction Data (ICDD), PDF of DL-propranolol hydrochloride, reference code: 00-051-2107, 2003 (acc. to Ammon HL, Howe DB, Erhardt WD, Balsamo A, Macchia B, Macchia F, Keefe WB. 1977. The crystal structures of dichloroisoproterenol, propranolol and propranolol hydrochloride. Acta Crystallogr B 33:21-29).
27. Bredikhin AA, Bredikhina ZA, Zakharychev DV, Konoshenko LV. 2007. Spontaneous resolution among chiral glycerol derivatives: Crystallization features of ortho-alkoxysubstituted phenyl glycerol ethers. Tetrahedron: Asymmetry 18:1964-1970.
28. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals, I. Mikrochim Acta II:259-271.
29. Bernstein J, Davey RJ, Henck J-O. 1999. Concomitant polymorphs. Angew Chem Int Ed 38:3440-3461.
30. Polenske D, Lorenz H, Seidel-Morgenstern A. 2007. Separation of the propranolol hydrochloride enantiomers by preferential crystallization - Thermodynamic basis and experimental verification. Cryst Growth Des 7:1628-1634.